Search
OrthoPediatrics Corp
KIDSAdd to Watchlist
17.720USD
-0.180-1.01%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
444.66MMarket Cap
LossP/E TTM
More Details of OrthoPediatrics Corp Company
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
OrthoPediatrics Corp Info
Ticker SymbolKIDS
Company nameOrthoPediatrics Corp
IPO dateOct 12, 2017
CEOBailey (David R)
Number of employees562
Security typeOrdinary Share
Fiscal year-endOct 12
Address2850 Frontier Drive
CityWARSAW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code46582
Phone15742686379
Websitehttps://www.orthopediatrics.com/
Ticker SymbolKIDS
IPO dateOct 12, 2017
CEOBailey (David R)
Company Executives of OrthoPediatrics Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
298.02K
--
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
--
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
21.23K
--
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
20.42K
--
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
19.77K
--
Ms. Kelly Fischer
Ms. Kelly Fischer
Director
Director
4.34K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
298.02K
--
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Trauma and Deformity
166.30M
70.36%
Scoliosis
66.05M
27.94%
Sports Medicine and Other
4.00M
1.69%
By RegionUSD
Name
Revenue
Proportion
U.S.
186.40M
78.87%
International
49.95M
21.13%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Trauma and Deformity
166.30M
70.36%
Scoliosis
66.05M
27.94%
Sports Medicine and Other
4.00M
1.69%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Squadron Capital LLC
26.87%
Brown Advisory
7.36%
Millennium Management LLC
5.44%
Braidwell LP
4.28%
BlackRock Institutional Trust Company, N.A.
4.21%
Other
51.83%
Shareholders
Shareholders
Proportion
Squadron Capital LLC
26.87%
Brown Advisory
7.36%
Millennium Management LLC
5.44%
Braidwell LP
4.28%
BlackRock Institutional Trust Company, N.A.
4.21%
Other
51.83%
Shareholder Types
Shareholders
Proportion
Corporation
26.87%
Investment Advisor/Hedge Fund
25.17%
Investment Advisor
21.41%
Hedge Fund
15.72%
Individual Investor
5.77%
Research Firm
4.75%
Venture Capital
0.47%
Bank and Trust
0.11%
Pension Fund
0.05%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
287
18.35M
71.44%
-360.87K
2025Q4
286
17.69M
70.55%
-1.38M
2025Q3
290
16.80M
66.98%
-2.63M
2025Q2
307
26.06M
103.94%
-977.48K
2025Q1
321
26.03M
105.09%
-1.19M
2024Q4
319
25.60M
105.70%
-1.27M
2024Q3
325
25.26M
104.34%
-2.01M
2024Q2
325
25.18M
104.01%
-1.27M
2024Q1
329
24.43M
104.11%
-1.85M
2023Q4
333
24.59M
105.32%
-1.43M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Squadron Capital LLC
6.90M
27.3%
--
--
Mar 28, 2025
Brown Advisory
1.89M
7.48%
-3.82K
-0.20%
Dec 31, 2025
Millennium Management LLC
1.40M
5.52%
+5.84K
+0.42%
Dec 31, 2025
Braidwell LP
1.10M
4.35%
-7.40K
-0.67%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.08M
4.28%
-4.73K
-0.44%
Dec 31, 2025
Wellington Management Company, LLP
1.02M
4.03%
-4.86K
-0.47%
Dec 31, 2025
Morgan Stanley & Co. LLC
881.82K
3.49%
-217.17K
-19.76%
Dec 31, 2025
Granahan Investment Management, LLC
663.98K
2.63%
-95.97K
-12.63%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
622.42K
2.46%
-97.41K
-13.53%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.42%
State Street SPDR S&P Health Care Equipment ETF
0.39%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.09%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Fund
0.02%
Humankind US Stock ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.42%
State Street SPDR S&P Health Care Equipment ETF
Proportion0.39%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.09%
iShares Micro-Cap ETF
Proportion0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.03%
WisdomTree US SmallCap Fund
Proportion0.02%
Humankind US Stock ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
